Cancer immunotherapies are revolutionizing clinical practice, yet only a fraction of patients derive clinical benefit, and some experience adverse events. To understand immune markers that impact clinical care, comprehensive data analyses across assay types and patient cohorts are being performed by NCI-supported Cancer Immune Monitoring and Analysis Centers (CIMACs) and Cancer Immunology Data Commons (CIDC). These represent 30+ cancer immunotherapy trials with longitudinal correlative data assayed using harmonized technology platforms. However, there is an unmet need for visual exploration of multi-scale multi-omic datasets. We introduce PRIMAVO, a unified platform that empowers users to visually explore, query, and subset the results of large-scale immune monitoring multi-omics datasets, spanning transcriptomics, proteomics, genomics, metagenomics, and multiplex immunohistochemistry (mIHC). Users can select specific clinical trials and patient subgroups based on key criteria including demographics, tumor, treatment, response and assay characteristics by leveraging interactive bar plots, pie charts, and scatter plots. For user-specified subgroups, PRIMAVO offers tailored visualizations of their multi-assay datasets: CyTOF, Olink, serology and RNA-seq data are represented within interactive heatmaps with on-the-fly filtering, querying, sorting and clustering. From mIHC imaging data, user-selected cell subsets and multiple markers can be explored simultaneously. Interactive oncoprints visually summarize genomic mutations. Developed in direct collaboration with CIMAC-CIDC scientists and utilizing React, TypeScript, Python, and Django frameworks, PRIMAVO provides domain-specific, downloadable, resizable, zoomable, and scrollable charts and figures. Overall, PRIMAVO lowers barriers between complex immune monitoring data in immunotherapy trials and researchers by providing intuitive, fast, and high-quality access to longitudinal multi-scale multi-omics datasets, facilitating research capabilities.